伊波拉病毒學概論：病毒構造與複製史

An Introduction to Ebola Virus: Virion Structure and Replication Cycle

劉旻禕(Helene Minyi Liu) ； 張淑媛(Sui-Yuan Chang)

《台灣醫學》 19卷2期 (2015/03) Pp. 133-142

https://doi.org/10.6320/FJM.2015.19(2).04

摘要

伊波拉病毒（EBOV）主要藉由接觸傳染，其感染會造成病人有嚴重出血症狀，致死率可高達50%至90%。伊波拉病毒屬於絲狀病毒科（Filoviridae），是具有套膜的病毒，其基因體是鏈狀的單股負性核糖核酸。因為伊波拉病毒屬於生物安全等級第四級的致病原，因此之前有關伊波拉病毒的研究因為實驗室等級的限制而比較緩慢，臨床治療上也以支持性療法為主。近年來在伊波拉病毒基因序列、病毒複製機制、轉譯控制機制及病毒蛋白構造方面有許多論文發表，因而可以幫助我們找出具潛力的抗病毒標的。本篇回顧論文主要敘述病毒構造、病毒蛋白的功能及它們在臨床上的重要性。

關鍵字

伊波拉病毒 ； 絲狀病毒 ； 核殼體 ； GP蛋白

並列摘要

Ebola virus (EBOV) is an emerging virus with great medical significance. Infection with EBOV, which is essentially transmitted by contacts, leads to severe hemorrhage diseases at a fatality rate of 50-90%. EBOV is an enveloped non-segmented negative-strand RNA virus that belongs to the ＂Filoviridae＂ family. EBOV is categorized as a Biosafety Level 4 (BSL4) agent, and therefore studies on EBOV progress slowly due to the limitation of research facilities. While current therapeutic options for EBOV are only supportive, recent advance in understanding EBOV molecular virology (genomic sequence, viral replication mechanisms, translational control mechanisms and the structures of viral proteins) led to the identification of potential new targets for antiviral strategies. This review focuses on the viral structure organization and protein functions along with their biological and clinical significance.

並列關鍵字

Ebola virus ； ＂Filoviridae＂ ； nucleocapsid ； GP protein

參考文獻

1. McCormick JB, Bauer SP, Elliott LH, et al: Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis 1983;147:264-7.

2. Noda T1, Aoyama K, Sagara H, et al: Nucleocapsid-like structures of Ebola virus reconstructed using electron tomography. J Vet Med Sci 2005;67:325-8.

3. Modrof J, Becker S, Mühlberger E: Ebola virus transcription activator VP30 is a zinc-binding protein. J Virol 2003;77:3334-8.

4. Hartlieb B, Modrof J, Mühlberger E, et al: Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J Biol Chem 2003;278:41830-6.

5. Modrof J, Mühlberger E, Klenk HD, et al: Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem 2002;277:33099- 104.